Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Jakarta International Hotels Development Tbk (JIHD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Jakarta International Hotels Development TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Jakarta International Hotels Development Tbk dan Brigit Biofarmaka Teknologi Tbk.: Jakarta International Hotels Development Tbk diperdagangkan di Rp430 (kapitalisasi pasar 987,51 M, volume 24 jam 401,3 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Jakarta International Hotels Development Tbk jauh lebih besar — sekitar 5,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Jakarta International Hotels Development Tbk lebih aktif diperdagangkan (401,3 rb vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

JIHDOBAT
Kapitalisasi Pasar
987,51 M167,37 M
Volume
401,3 rb96,7 rb
Lot
4,01 rb967
Perputaran
173,08 jt23,82 jt
Harga Rata-rata
431,29246,34
Nilai Transaksi
173,08 jt23,82 jt
Harga Ekuilibrium Indikatif
430248
Volume Ekuilibrium Indikatif
2541

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

JIHD
Lihat detail
OBAT
Lihat detail

Tentang Jakarta International Hotels Development Tbk

PT Jakarta International Hotels and Development Tbk (the Company) was established on November 7, 1967. The Company is the owner of Hotel Borobudur (“the Hotel”) which had been managed and operated by Inter-Continental Hotels (Indonesia) BV (Operator) until December 31, 1998. Starting January 1, 1999, the Hotel has been operated by PT Dharma Harapan Raya 60% of whose shares are owned by the Company.

Selengkapnya di halaman JIHD

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT